SCHEMBL5589366

SCHEMBL5589366

CCCc1ccc(OC(=O)O)c(O)c1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.38
ELANE P08246 2/20 0.38
PDE4A P27815 2/20 0.37
PDE4B Q07343 2/20 0.37
PDE4C Q08493 2/20 0.37
PDE4D Q08499 2/20 0.37
CNR2 P34972 1/20 0.36
KDM4E B2RXH2 3/20 0.35
GAA P10253 2/20 0.35
CTSG P08311 1/20 0.35
ALDH1A1 P00352 2/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RCE1 Q9Y256 1/20 0.35
NCEH1 Q6PIU2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587746 0.92 CNR2 (0.40) ELANECNR2KDM4ECTSGALDH1A1
SCHEMBL5587942 0.90 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL1834263 0.82 LTB4R (0.41) ELANEKDM4EGAAALDH1A1NPC1
SCHEMBL5589189 0.82 PPARG (0.38) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL5586756 0.82 CNR2 (0.37) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL5588022 0.81 LTB4R (0.38) PDE4APDE4BPDE4CPDE4DCNR2
SCHEMBL5195489 0.79 PRKCI (0.41) PRKCIELANEMAPTALOX5
SCHEMBL5588622 0.79 PRKCI (0.41) PRKCILMNAMAPTNCEH1
SCHEMBL5680760 0.78 PRKCI (0.41) PRKCIELANELMNAMAPT
SCHEMBL5678227 0.77 ALOX5 (0.51) PRKCIELANEALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 PRKCI 4727/4885ELANE 3887/4885PDE4A 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.